| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $490.4M | +12.7% |
| Cost of Revenue | $354.4M | +8.3% |
| Gross Profit | $136.0M | +25.9% |
| R&D Expense | $64.7M | +9.6% |
| SG&A Expense | $55.9M | +13.0% |
| Operating Income | -$56.9M | +5.4% |
| Pre-tax Income | -$55.7M | -0.5% |
| Income Tax | $975K | +44.0% |
| Net Income | -$56.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $84.0M | -52.2% |
| Accounts Receivable | $66.0M | -17.1% |
| Inventory | $46.6M | +21.3% |
| Current Assets | $232.8M | -23.3% |
| Total Assets | $272.2M | -21.7% |
| Current Liabilities | $162.3M | -23.1% |
| Total Liabilities | $184.5M | -21.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$46.0M | -98.1% |
| Capital Expenditures | $2.0M | -11.4% |
| Investing Cash Flow | -$31.8M | -279.2% |
| Financing Cash Flow | -$13.9M | -180.5% |
| Free Cash Flow | -$48.0M | -88.4% |
| -1.1% |
| EPS (Basic) | -$0.65 | +4.4% |
| EPS (Diluted) | -$0.65 | +4.4% |
| Stockholders' Equity |
| $87.7M |
| -22.2% |